References
- Delbet P. Retrecessement du choledoque: chole-cystoduodenostomie. Bull Mem Soc Nat Chir 1924; 50: 1144
- Chapman R W, Varghese Z, Gaul R, Patel G, Kokinon N, Sherlock S. Association of primary sclerosing cholangitis with HLA-B8. Gut 1983; 24: 38–41
- Schrumpf E, Fausa O, Førre O, Dobloug H, Ritland S, Thorsby E. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepato-biliary disease. Scand J Gastrotenterol 1982; 17: 187–191
- McFarlane I G, Wojcicka B M, Tsantoulas D c, Portmann B C, Eddleston A L W F, Williams R. Leukocyte migration inhibition in response to biliary antigens in primary biliary cirrhosis, sclerosing cholangitis and other chronic liver diseases. Gastroenterology 1979; 76: 1333–1340
- Bodenheimer H C, La Russo N F, Thayer W R, Jr, Charland C, Staples P J, Ludwig J. Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology 1983; 3: 150–154
- Chapman R W, Cottone M, Selby W S, Shepherd H A, Sherlock S, Jewell D P. Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut 1986; 27: 86–91
- Zauli D, Schrumpf E, Crespi C, Cassani F, Fausa O, Aadland E. An autoantihody profile in primary sclerosing cholangitis. Hepatology 1987; 5: 14–18
- La Russo N F, Wiesner R H, Ludwig J. Is mimary sclerosing cholangitis a bad disease?. Gastroen-terology 1987; 92: 2031–2033
- Klareskog L, Forsum U. HLA class antigens. Tissue distribution of class II transplantation antigens: presence of normal cells, B G Solheim, E Mö, S Ferrone. Springer Verlag, Berlin 1986; 339–355
- Barbatis C, Kelly P, Greveson J, Heryet A, McGee J O'D. Immunocytochemical analysis of HLA class II (DR) antigens in liver disease in man. J Clin Pathol 1987; 40: 879–884
- Chapman R W, Kelly P M A, Heyret A, Jewell D P, Fleming K A. Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis. Gut 1988; 29: 422–427
- Claesson K, Forsum U, Tufveson G, Wahlberg J. Expression of HLA-DR and -DQ antigens on cells in normal and transplanted kidneys. Transplant Proc 1986; 8: 9–12
- Ballardini G, Bianchi F B, Mirakian R, Fallani M, Pisi E, Bottazzo G F. HLA-A,B,C, HLA-D/DR and HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease. Clin Exp Immunol 1987; 70: 35–46
- Pollack M S, Chin-Louie J, Moshief R D. Functional characteristics and differential expression of class II DR, DS and SB antigens on human melanoma cell lines. Hum Immunol 1984; 9: 75–87
- Chapman R W, Arborgh B A M, Rhodes J M, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980; 21: 870–877
- Ludwig J, Barham S S, LaRusso N F, Elvehack L R, Wiesner R H, McCall J T. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1981; 1: 632–640
- Karlsson-Parra A, Tötterman T H, Nyberg A, Mendel-Hartvig I, Lööf L, Forsum U. Immunological effects of ciclosporin in primary biliary cirrhosis: suppression of activated T cells and autoantibody levels. Int Arch Allergy Appl Immunol 1987; 83: 256–264
- Forsum U, Claesson K, Jonsson R, et al. Differential tissue distribution of HLA-DR, -DP and -DQ antigens. Adv Exp Med Biol 1987; 216A: 233–239
- Halloran P F, Wadgymar A, Autentied P. The regulation of expression of major histocompatibility complex products. Transplantation 1986; 41: 413–4211
- Spengler U, Pape G R, Hoffmann R M, et al. Differential expression of MHC class subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis. Hepatology 1988; 8: 459–462
- MacSween K N M, Anthony P P, Scheuer P J. Pathology of the liver. Churchill Livingstone, London 1987; 436–441
- Chapman R W G, Burroughs A K, Bass N M, Sherlock S. Long-standing asymptomatic primary sclerosing cholangitis. Dig Dis Sci 1981; 26: 778–782